ONCY - Oncolytics Biotech Inc. (ONCY) CEO Matthew Coffey on Q1 2022 Results - Earnings Call Transcript

Oncolytics Biotech, Inc. (ONCY) Q1 2022 Earnings Conference Call May 5, 2022 17:00 ET Corporate Participants Jon Patton - Director, Investor Relations and Communications Matthew Coffey - President and Chief Executive Officer Thomas Heineman - Chief Medical Officer Andrew de Guttadauro - Global Head of Business Development, President, Oncolytics Biotech (U.S.) Inc. Kirk Look - Chief Financial Officer Conference Call Participants John Newman - Canaccord Jason Kolbert - HC Wainwright Presentation Operator Good afternoon, and welcome to Oncolytics Biotech's First Quarter 2022 Conference Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised that this call is being recorded at the company's request. I would now like to turn the conference call over to Mr. Jon Patton, Director of Investor Relations and Communications. Please go ahead. Jon Patton Thank you, operator, and good afternoon to all

For further details see:

Oncolytics Biotech, Inc. (ONCY) CEO Matthew Coffey on Q1 2022 Results - Earnings Call Transcript